Jan L. Posma

1.5k total citations
15 papers, 989 citations indexed

About

Jan L. Posma is a scholar working on Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Organic Chemistry. According to data from OpenAlex, Jan L. Posma has authored 15 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 2 papers in Clinical Biochemistry and 1 paper in Organic Chemistry. Recurrent topics in Jan L. Posma's work include Cardiovascular Function and Risk Factors (7 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Cardiomyopathy and Myosin Studies (5 papers). Jan L. Posma is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Cardiomyopathy and Myosin Studies (5 papers). Jan L. Posma collaborates with scholars based in Netherlands, United States and Greece. Jan L. Posma's co-authors include Aeilko H. Zwinderman, Arie van Tol, Greetje J. de Grooth, Anton F. H. Stalenhoef, Jacqueline de Graaf, John J.P. Kastelein, Jan Albert Kuivenhoven, Harry J. Crijns, K.I. Lie and Paul K. Blanksma and has published in prestigious journals such as Circulation, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Jan L. Posma

15 papers receiving 945 citations

Peers

Jan L. Posma

CCM

SURGE

EDM

S. Lale Tokgözoğlu Türkiye

Kei Yunoki Japan

Takafumi Hiro Japan

Daniel Brun Canada

G. R. Thompson United Kingdom

Amanda J. Berberich Canada

C. Abletshauser Germany

Christelle Foucher France

J. L. de Gennes France

Greetje J. de Grooth Netherlands

S. Lale Tokgözoğlu Türkiye

Jan L. Posma

368 ×0.6

CCM

736 ×2.2

SURGE

223 ×0.8

EDM

143 ×1.2

32 ×0.4

Citations per year, relative to Jan L. Posma Jan L. Posma (= 1×) peers S. Lale Tokgözoğlu

Countries citing papers authored by Jan L. Posma

Since Specialization

Citations

This map shows the geographic impact of Jan L. Posma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan L. Posma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan L. Posma more than expected).

Fields of papers citing papers by Jan L. Posma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan L. Posma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan L. Posma. The network helps show where Jan L. Posma may publish in the future.

Co-authorship network of co-authors of Jan L. Posma

This figure shows the co-authorship network connecting the top 25 collaborators of Jan L. Posma. A scholar is included among the top collaborators of Jan L. Posma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan L. Posma. Jan L. Posma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wijtvliet, Petra, Nic J.G.M. Veeger, G. L. Bartels, et al.. (2016). Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation. EP Europace. 18(9). 1319–1327. 29 indexed citations

Tieleman, Robert G, et al.. (2014). Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. EP Europace. 16(9). 1291–1295. 91 indexed citations

Hartog, Jasper W.L., Suzan Willemsen, Dirk J. van Veldhuisen, et al.. (2011). Effects of Alagebrium, an Advanced Glycation Endproduct Breaker, on Exercise Tolerance and Cardiac Function in Patients with Chronic Heart Failure. European Journal of Heart Failure. 13(8). 899–908. 99 indexed citations

Willemsen, Suzan, Jasper W.L. Hartog, Yoran M. Hummel, et al.. (2010). Effects of Alagebrium, an Advanced Glycation End-Product Breaker, in Patients with Chronic Heart Failure: Study Design and Baseline Characteristics of the BENEFICIAL Trial. European Journal of Heart Failure. 12(3). 294–300. 44 indexed citations

Grooth, Greetje J. de, Jan Albert Kuivenhoven, Anton F. H. Stalenhoef, et al.. (2002). Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans. Circulation. 105(18). 2159–2165. 359 indexed citations

Posma, Jan L., Paul K. Blanksma, Ernst E. van der Wall, et al.. (1996). Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: Magnetic resonance imaging versus echocardiography. American Heart Journal. 132(5). 1020–1027. 28 indexed citations

Posma, Jan L., et al.. (1996). New diagnostic options in hypertrophic cardiomyopathy. American Heart Journal. 132(5). 1031–1041. 8 indexed citations

Posma, Jan L., P. K. Blanksma, & Ernst E. van der Wall. (1996). Redistribution of myocardial perfusion during permanent dual chamber pacing in symptomatic non-obstructive hypertrophic cardiomyopathy: a quantitative positron emission tomography study.. Heart. 75(5). 522–524. 11 indexed citations

Posma, Jan L., P. K. Blanksma, Ernst E. van der Wall, et al.. (1996). Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy.. Heart. 76(4). 358–362. 18 indexed citations

10.

Tieleman, R. G., Harry J. Crijns, Ans C.P. Wiesfeld, et al.. (1995). Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias.. Heart. 73(1). 37–40. 54 indexed citations

11.

Crijns, Harry J.G.M., Ans C.P. Wiesfeld, Jan L. Posma, & K. I. Lie. (1995). Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias.. Heart. 74(4). 408–412. 20 indexed citations

12.

Posma, Jan L., et al.. (1994). Acute Intravenous Versus Chronic Oral Drug Effects of Verapamil on Left Ventricular Diastolic Function in Patients with Hypertrophic Cardiomyopathy. Journal of Cardiovascular Pharmacology. 24(6). 969–973. 3 indexed citations

13.

Gelder, Isabelle C. Van, Harry J. Crijns, Paul K. Blanksma, et al.. (1993). Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. The American Journal of Cardiology. 72(7). 560–566. 207 indexed citations

14.

Posma, Jan L., et al.. (1989). Sustained-release diltiazem versus metoprolol in stable angina pectoris. European Heart Journal. 10(10). 923–927. 9 indexed citations

15.

Posma, Jan L., et al.. (1988). Noninvasive measurement of right ventricular systolic pressure by combined color-coded and continuous-wave Doppler ultrasound. The American Journal of Cardiology. 61(8). 668–671. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact